Highlights from this edition:
- Gedi Cube was acquired by Renovaro Biosciences Inc. (NasdaqCM:RENB)
- Repligen Corporation (NasdaqGS:RGEN) announced its acquisition of Metenova AB
- Harbinger Health closed a $140MM Series A Financing, led by Flagship Pioneering